The two startups NeoCura and PhoreMost announce research collaboration to explore novel cancer therapeutics
19-Jan-2022 -
NeoCura Bio-Medical Technology Co., Ltd., a RNA-based drug research and development company in China, and PhoreMost Limited, the UK-based biopharmaceutical company dedicated to ‘Drugging the Undruggable®’, announced an oncology drug discovery research collaboration
As part of the collaboration, ...
cancer
cancer drugs
cancer therapeutics
+2